Merck’s Enlicitide Decanoate Achieves Key Breakthrough in Cholesterol Trials
Merck’s experimental drug Enlicitide Decanoate has achieved significant success in two late-stage clinical trials, the company announced on June 9, 2025. The trials demonstrated the drug’s ability to substantially lower LDL-C levels, commonly referred to as bad cholesterol, in patients with hyperlipidemia, a condition involving high-fat buildup in blood vessels.
The drug was tested in individuals with a history of, or high risk for, heart disease. Results confirmed meaningful reductions in LDL-C levels, making Enlicitide Decanoate a promising candidate for managing cholesterol-related health risks.
Hyperlipidemia is a key driver of cardiovascular disease globally, and Merck’s breakthrough has the potential to transform treatment strategies for millions of at-risk patients.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$169/UNIT FOB
2026-10-24
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
COSMAX Acquires 51% Stake in Keminova, Establishes First European Production Base
-
Can the Manufacturing Sector Withstand Dow’s April Polyethylene Price Doubling?
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
BASF Launches Global Expansion Plan for Aroma Ingredients
-
BASF Launches Global Expansion Plan for Aroma Ingredients
-
Shell Polymers Explosion Caused About $95 Million in Damage, U.S. CSB Finds
-
Wanhua Chemical Establishes a RMB 1.488 Billion New Energy Materials Company in Weifang, Further Integrating Green Power and Battery Materials Businesses
-
Indorama Secures RMB 2.4 Billion Loan to Expand Urea Capacity in Anyang
-
Supply Chain Resilience Reshapes Chemical Competition: What Lies Behind BASF’s Stable Outlook
-
Beiersdorf Launches Eucerin Skincare Brand in Japan
Recommend Reading
-
![From LANXESS’s 50% to Tire Makers’ 5%: The Rubber Industry Chain Is Experiencing a “Decreasing-Cost Transmission”]()
From LANXESS’s 50% to Tire Makers’ 5%: The Rubber Industry Chain Is Experiencing a “Decreasing-Cost Transmission”
-
![OCI Exits TDI Business and Joins South Korean Semiconductor Materials Cluster on the Same Day]()
OCI Exits TDI Business and Joins South Korean Semiconductor Materials Cluster on the Same Day
-
![Soybeans Tread Water Amid Trade Whispers and Biofuel Hopes]()
Soybeans Tread Water Amid Trade Whispers and Biofuel Hopes
-
![Wanhua Chemical Announces MDI Price Hike Across South and Southeast Asia]()
Wanhua Chemical Announces MDI Price Hike Across South and Southeast Asia
-
![Sika Strengthens Gulf Foothold with Strategic Acquisition of Gulf Seal]()
Sika Strengthens Gulf Foothold with Strategic Acquisition of Gulf Seal
-
![Business Society September 29, 2026 PTA Trend Analysis: Volatility]()
Business Society September 29, 2026 PTA Trend Analysis: Volatility
-
![Trade Structure Continues to Optimize, Acrylic Acid Export Dominance Further Consolidated in August]()
Trade Structure Continues to Optimize, Acrylic Acid Export Dominance Further Consolidated in August
-
![Business Society September 28, 2026 Isooctanol Trend Analysis: Strong Rebound with a Bullish Bias]()
Business Society September 28, 2026 Isooctanol Trend Analysis: Strong Rebound with a Bullish Bias
-
![Business Society September 24, 2026 BDO Trend Analysis: Strong Volatility]()
Business Society September 24, 2026 BDO Trend Analysis: Strong Volatility
-
![Business Society September 28, 2026 Adipic Acid Trend Analysis: Clear Decline]()
Business Society September 28, 2026 Adipic Acid Trend Analysis: Clear Decline
